Brief Article
Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Jul 7, 2013; 19(25): 4066-4071
Published online Jul 7, 2013. doi: 10.3748/wjg.v19.i25.4066
Clinical significance of melatonin concentrations in predicting the severity of acute pancreatitis
Yin Jin, Chun-Jing Lin, Le-Mei Dong, Meng-Jun Chen, Qiong Zhou, Jian-Sheng Wu
Yin Jin, Chun-Jing Lin, Le-Mei Dong, Meng-Jun Chen, Qiong Zhou, Jian-Sheng Wu, Department of Gastroenterology, First Affiliated Hospital of Wenzhou Medical College, Wenzhou 325000, Zhejiang Province, China
Author contributions: Wu JS designed the research; Jin Y, Dong LM and Zhou Q performed the research; Lin CJ and Chen MJ provided analytic tools; Jin Y wrote the paper.
Supported by The Wenzhou Municipal Science and Technology Commission Major Projects Funds, No. 20090006
Correspondence to: Jian-Sheng Wu, Professor of Medicine, Department of Gastroenterology, First Affiliated Hospital of Wenzhou Medical College, No. 2 Xuefu Road, Lucheng District, Wenzhou 325000, Zhejiang Province, China. wzwujs@163.com
Telephone: +86-577-55559191 Fax: +86-577-55559192
Received: December 19, 2012
Revised: April 15, 2013
Accepted: June 5, 2013
Published online: July 7, 2013
Processing time: 199 Days and 1.3 Hours
Abstract

AIM: To assess the value of plasma melatonin in predicting acute pancreatitis when combined with the acute physiology and chronic health evaluation II (APACHEII) and bedside index for severity in acute pancreatitis (BISAP) scoring systems.

METHODS: APACHEII and BISAP scores were calculated for 55 patients with acute physiology (AP) in the first 24 h of admission to the hospital. Additionally, morning (6:00 AM) serum melatonin concentrations were measured on the first day after admission. According to the diagnosis and treatment guidelines for acute pancreatitis in China, 42 patients suffered mild AP (MAP). The other 13 patients developed severe AP (SAP). A total of 45 healthy volunteers were used in this study as controls. The ability of melatonin and the APACHEII and BISAP scoring systems to predict SAP was evaluated using a receiver operating characteristic (ROC) curve. The optimal melatonin cutoff concentration for SAP patients, based on the ROC curve, was used to classify the patients into either a high concentration group (34 cases) or a low concentration group (21 cases). Differences in the incidence of high scores, according to the APACHEII and BISAP scoring systems, were compared between the two groups.

RESULTS: The MAP patients had increased melatonin levels compared to the SAP (38.34 ng/L vs 26.77 ng/L) (P = 0.021) and control patients (38.34 ng/L vs 30.73 ng/L) (P = 0.003). There was no significant difference inmelatoninconcentrations between the SAP group and the control group. The accuracy of determining SAP based on the melatonin level, the APACHEII score and the BISAP score was 0.758, 0.872, and 0.906, respectively, according to the ROC curve. A melatonin concentration ≤ 28.74 ng/L was associated with an increased risk of developing SAP. The incidence of high scores (≥ 3) using the BISAP system was significantly higher in patients with low melatonin concentration (≤ 28.74 ng/L) compared to patients with high melatonin concentration (> 28.74 ng/L) (42.9% vs 14.7%, P = 0.02). The incidence of high APACHEII scores (≥ 10) between the two groups was not significantly different.

CONCLUSION: The melatonin concentration is closely related to the severity of AP and the BISAP score. Therefore, we can evaluate the severity of disease by measuring the levels of serum melatonin.

Keywords: Pancreatitis; Melatonin concentrations; Predict; Cutoff; Bedside index for severity in acute pancreatitis; Acute physiology and chronic health evaluation II

Core tip: It is important to assess the severity and changes in a patient’s condition in a timely and accurate manner. Thus, a comprehensive treatment plan for acute pancreatitis patients is critical. Melatonin plays a protective role in the early course of human acute pancreatitis, and melatonin concentration variations are closely related to the severity of acute pancreatitis and the bedside index for severity in acute pancreatitis score. We can determine the severity of disease in the clinic more objectively, accurately and rapidly by measuring the levels of serum melatonin than by using the standard scoring systems. When the serum concentration of melatonin is below 28.74 ng/L, it is possible that acute pancreatitis patients will develop severe acute pancreatitis.